Skip Navigation


JAC Advance Access originally published online on February 1, 2008
Journal of Antimicrobial Chemotherapy 2008 61(3):509-514; doi:10.1093/jac/dkm523
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
61/3/509    most recent
dkm523v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tristram, S. G.
Right arrow Articles by Davidson, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tristram, S. G.
Right arrow Articles by Davidson, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Characterization of extended-spectrum β-lactamase-producing isolates of Haemophilus parainfluenzae

Stephen G. Tristram1,*, Marthinus J. Pitout2, Karen Forward3, Sarah Campbell4, Scott Nichols1 and Ross J. Davidson3,4

1 School of Human Life Sciences, University of Tasmania, Launceston, Tasmania 7250, Australia 2 University of Pretoria, Pretoria, South Africa 3 Dalhousie University, Halifax, Canada 4 Queen Elizabeth II Health Sciences Centre, Halifax, Canada

Received 9 September 2007; returned 28 November 2007; revised 20 November 2007; accepted 10 December 2007


* Corresponding author. Tel: +61-3-63-243323; Fax: +61-3-63-243658; E-mail: stephen.tristram{at}utas.edu.au

Objectives: To characterize the β-lactam resistance mechanisms of two clinical isolates of cefotaxime-resistant Haemophilus parainfluenzae recovered from patients in South Africa.

Methods: The relatedness of isolates and plasmids was assessed using PFGE and restriction enzyme analysis, respectively. Plasmid-mediated and chromosomally integrated blaTEM genes and ftsI genes were sequenced, and the plasmid-mediated blaTEM-15 was used to transform a range of control organisms.

Results: The two isolates were found to be unique according to PFGE, but had an identical 3.7 kb plasmid encoding a TEM-15 β-lactamase. Both isolates also had substitutions in penicillin binding protein 3 (PBP3) consistent with substitutions known to exist in β-lactamase-negative ampicillin-resistant (BLNAR) strains of Haemophilus influenzae. The cefotaxime MICs for control strains of H. influenzae, H. parainfluenzae and BLNAR H. influenzae transformed with the plasmid-mediated blaTEM-15 were 1.0, 1.0 and 4.0 mg/L, respectively, compared with 16.0 and 8.0 mg/L, respectively, for the two parent H. parainfluenzae.

Conclusions: The high-level cefotaxime resistance in the H. parainfluenzae isolates was due to a combination of a plasmid-mediated TEM-15 extended-spectrum β-lactamase with altered PBP3 probably contributing. Other contributing resistance mechanisms could not be excluded.

Keywords: plasmid , ftsI , TEM , ESBL , PBP3 , promoter , penicillin binding protein


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.